SCHEMBL7610047

SCHEMBL7610047

CC(C)(C)n1cc(C(=O)O)c(=O)c2cc(F)c(N3C[C@@H]4OCCN[C@@H]4C3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.45
KDM4E B2RXH2 8/20 0.45
LMNA P02545 7/20 0.45
HSD17B10 Q99714 5/20 0.45
HPGD P15428 5/20 0.45
HTT P42858 2/20 0.45
CYP1A2 P05177 1/20 0.45
TOP2A P11388 1/20 0.45
CYP2C9 P11712 1/20 0.45
TOP2B Q02880 1/20 0.45
BRD4 O60885 1/20 0.45
TSHR P16473 1/20 0.45
CYP2J2 P51589 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
DRD3 P35462 1/20 0.42
MAPT P10636 1/20 0.41
TOP1 P11387 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610610 0.93 ALDH1A1 (0.46) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL7614577 0.92 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL7620518 0.92 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL7610053 0.89 ALDH1A1 (0.36) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL8982890 0.85 KDM4E (0.65) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL8982877 0.85 KDM4E (0.65) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL8982910 0.85 KDM4E (0.65) ALDH1A1KDM4ELMNAHSD17B10HPGD
Hydrochloric Acid SCHEMBL8982744 0.84 KDM4E (0.64) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL7657864 0.83 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL7668621 0.83 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946176-B1 THE USE OF 7-(2-OXA-5,8-DIAZABICYCLO 4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES BAYER AG (DE) 2002-03-27 EP disclosed